Secondary Myelofibrosis Completed Phase 0 Trials for Cyclophosphamide (DB00531)

IndicationStatusPhase
DBCOND0030964 (Secondary Myelofibrosis)Completed0
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03426969Combination Chemotherapy, Total Body Irradiation, and Donor Blood Stem Cell Transplant in Treating Patients With Primary or Secondary MyelofibrosisTreatment